Furthermore, the lack of in vitro experimental verification is another limitation, as the anti-UC effect of HLD was only validated through in vivo experiments inhibiting the TLR4/MyD88/NF-κB pathway. This evidence concerns the gene NFKB1 and leukodystrophy.